中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
5-O-(4,4-二甲氧基三苯甲基)-2-O-[(叔丁基)二甲基硅基]尿苷-3-(2-氰基乙基-N,N-二异丙基)亚磷酰胺 | 5'-O-(4,4'-dimethoxytrityl)-2'-O-(tert-butyldimethylsilyl)uridine-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]phosphoramidite | 118362-03-1 | C45H61N4O9PSi | 861.06 |
5’-O-(4,4’-二甲氧基三苯甲基)尿苷 | 5'-dimethoxytrityluridine | 81246-79-9 | C30H30N2O8 | 546.577 |
2'-O-叔丁基二甲基硅烷基尿苷 | 2'-O-(tert-butyldimethylsilyl)uridine | 54925-71-2 | C15H26N2O6Si | 358.467 |
尿嘧啶核苷 | uridine | 58-96-8 | C9H12N2O6 | 244.204 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 5'-O-dimethoxytrityl-2'-O-tert-butyldimethylsilyluridine 3'-N,N-diisopropylmethyl phosphoramidite | 114207-67-9 | C43H60N3O9PSi | 822.023 |
—— | 4-S-(2-cyanoethyl)-2'-O-(tert-butyldimethylsilyl)-5'-O-(4,4'-dimethoxytrityl)-4-thiouridine | 154665-03-9 | C39H47N3O7SSi | 729.97 |
5-O-(4,4-二甲氧基三苯甲基)-2-O-[(叔丁基)二甲基硅基]尿苷-3-(2-氰基乙基-N,N-二异丙基)亚磷酰胺 | 5'-O-(4,4'-dimethoxytrityl)-2'-O-(tert-butyldimethylsilyl)uridine-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]phosphoramidite | 118362-03-1 | C45H61N4O9PSi | 861.06 |
—— | 2'-O-(tert-butyldimethylsilyl)-5'-O-(p,p'-dimethoxytrityl)uridine 3'-O-(allyl N,N-disopropylphosphoramidite) | 185628-22-2 | C45H62N3O9PSi | 848.061 |
—— | 1-[(2R,3S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-oxooxolan-2-yl]pyrimidine-2,4-dione | 179026-52-9 | C36H42N2O8Si | 658.824 |
—— | 5′-O-(4,4-dimethoxytrityl)-2′-O-(tert-butyldimethylsilyl)-uridine 3′-N,N-dimethyl-S-(2,4-dichlorobenzyl)phosphorothioamidite | —— | C45H54Cl2N3O8PSSi | 926.97 |
—— | 1-[(2R,3R,5S)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-(difluoromethylidene)oxolan-2-yl]pyrimidine-2,4-dione | 179026-54-1 | C37H42F2N2O7Si | 692.832 |
—— | 5'-O-(4,4'-dimethoxytrityl)-2'-O-(tert-butyldimethylsilyl)uridylyl (3'-5') 5'-amino-5'-deoxyuridine | 182005-97-6 | C45H56N5O15PSi | 966.023 |
—— | (Rp/Sp)-5'-O-(4,4'-dimethoxytrityl)-2'-O-(tert-butyldimethylsilyl)uridylyl (3'-5')-5'-amino-5'-deoxyuridine methyl ester | —— | C46H58N5O15PSi | 980.05 |
2'-O-叔丁基二甲基硅烷基尿苷 | 2'-O-(tert-butyldimethylsilyl)uridine | 54925-71-2 | C15H26N2O6Si | 358.467 |
—— | [(2R,3R,4R,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]phosphonamidic acid | 182006-00-4 | C24H38N5O13PSi | 663.651 |
—— | 1-[2-O-(tert-butyldimethylsilyl)-β-D-erythro-pentofuran-3-ulosyl]uracil | 162611-11-2 | C15H24N2O6Si | 356.451 |
尿苷酰基-(3',5')-尿苷 | uridylyl-3',5'-uridine | 2415-43-2 | C18H23N4O14P | 550.373 |
—— | uridylyl (3'-5') 5'-amino-5'-deoxyuridine | 182005-90-9 | C18H24N5O13P | 549.388 |
A modified phosphotriester method has been successfully applied for the chemical synthesis of ribooligonucleotides. The starting material is a fully protected ribomononucleoside containing a 3′-phosphotriester group 5. The coupling reaction is performed using mesitylenesulfonyl tetrazole and purification of the product achieved using reversed phase column chromatography. The effectiveness of this method has been demonstrated by achieving an efficient and rapid synthesis of r-A7, r-A11, r5′-AAACAUGAGGA-3′, and r5′-UUACCCAUGU-3′ (R-17, translation control sequence).